Palliative CareNCT04864613
The Importance of ENDING-S Score in the Diagnosis of Palliative Patients in the Intensive Care Unit
An observational study of Palliative Care and Critical Care, run by Ankara City Hospital Bilkent at 1 site in Turkey (Türkiye).
Trial summary
In our study, we aim to predict palliative care patients earlier, to reduce hospitalization periods and to prevent intensive care unit occupation by palliative care patients. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Palliative Care, Critical Care, Length of Stay
- How many people
- 135 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Jun 2019to 30 Dec 2020
- How long will I take part?
- 30 Days
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Intensive care patients
Who may be able to join
- Patients older than 18 years will be included in the study. Patients staying longer than 48 hours intensive care will be included in the study.
Who cannot join
- Patients younger than 18 years. Patients staying less than 48 hours
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Ministry of Health Ankara City Hospital
Ankara, 06800
About this study
In our study, we aim to predict palliative care patients earlier, to reduce hospitalization periods and to prevent intensive care unit occupation by palliative care patients.
- Conditions
- Palliative Care, Critical Care, Length of Stay
What is being measured
The primary outcome is the main question the study is designed to answer.
Recognition of palliative care unit patients before intensive care discharge
ENDING-S Scoring system used to predict patients who were followed up in intensive care units and discharged to palliative care unit during their hospitalization. We aim to identify patients who are likely to be admitted to palliative care centers following their admission to intensive care units, and to prepare a palliative care center before the discharge from the intensive care.
Measured: Fourth day of intensive care follow up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Apr 2021
- Study start1 Jun 2019
- Primary completion8 Jul 2020
- Study completion30 Dec 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Palliative CareStudies of the same condition, open and under way.
- More trials run by Ankara City Hospital BilkentThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 135 participants (actual)
- Target duration
- 30 Days
Sponsor and investigators
- Lead sponsor
- Ankara City Hospital Bilkent
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Cihangir Dogu, Ankara City Hospital Bilkent
- Investigators
- Işıl Özkoçak Turan, Prof., Study director, Ministry of Health Ankara City Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04864613
- Sponsor's protocol ID
- 2636
- Status last verified
- Apr 2021
- First submitted
- 30 Jan 2021
- Last updated
- 29 Apr 2021
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Apr 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Importance of ENDING-S Score in the Diagnosis of Palliative Patients in the Intensive Care Unit
- ClinicalTrials.gov ID
- NCT04864613
- Acronym / sponsor ID
- 2636
- Conditions
- Palliative Care, Critical Care, Length of Stay
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 135 participants (actual)
- Lead sponsor
- Ankara City Hospital BilkentUniversity, hospital or other
- Study start
- 1 Jun 2019 (actual)
- Primary completion
- 8 Jul 2020 (actual)
- Study completion
- 30 Dec 2020 (actual)
- First posted
- 29 Apr 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In our study, we aim to predict palliative care patients earlier, to reduce hospitalization periods and to prevent intensive care unit occupation by palliative care patients.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 30 Days
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Intensive care patients
Key inclusion criteria (1 listed)
- Patients older than 18 years will be included in the study. Patients staying longer than 48 hours intensive care will be included in the study.
Key exclusion criteria (1 listed)
- Patients younger than 18 years. Patients staying less than 48 hours
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Recognition of palliative care unit patients before intensive care discharge
Time frame: Fourth day of intensive care follow up
ENDING-S Scoring system used to predict patients who were followed up in intensive care units and discharged to palliative care unit during their hospitalization. We aim to identify patients who are likely to be admitted to palliative care centers following their admission to intensive care units, and to prepare a palliative care center before the discharge from the intensive care.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Apr 2021.
- Individual participant dataSharing planned: No
Related trials for Palliative Care
Not yet recruitingObservational study
IN-TALK: Co-producing a Hospice Intimacy Support Toolkit in England
Communication About Intimacy Needs in Hospice and Palliative Care
Not yet recruitingPhase 2
Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
RecruitingPhase 1/2
Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction
Malignant Solid Neoplasm
Active, not recruiting
LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
Liver Disease Chronic, End Stage Liver DIsease
Not yet recruiting
Comparing Radiotherapy Dose Strategies for Symptom Relief in Large Solid Tumors
Solid Tumor
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Işıl Özkoçak Turan, Prof. study director
Ministry of Health Ankara City Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Palliative Care and Critical Care, run by Ankara City Hospital Bilkent at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Recognition of palliative care unit patients before intensive care discharge (time frame: Fourth day of intensive care follow up). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2021.